Allergy Therapeutics plc (AGY.L)

GBp 6.4

(0.0%)

Annual Balance Sheets

(In GBP)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 66.76 Million 72.94 Million 88.08 Million 86.22 Million 68.49 Million 51.01 Million
Total Current Assets 33.52 Million 42.39 Million 57.85 Million 55.17 Million 46.62 Million 30.92 Million
Cash And Short Term Investments 14.84 Million 20.51 Million 40.27 Million 36.96 Million 27.44 Million 15.53 Million
Cash and Cash Equivalents 14.84 Million 20.51 Million 40.27 Million 36.96 Million 27.44 Million 15.53 Million
Short Term Investments - - - - - -
Net Receivables 7.08 Million 10.46 Million 6.22 Million 8.07 Million 4.49 Million 3.82 Million
Inventory 11.59 Million 11.41 Million 10.83 Million 10.13 Million 9.4 Million 8.8 Million
Other Current Assets 4.72 Million 7.77 Million 525 Thousand 4.58 Million 5.28 Million 2.76 Million
Total Non-Current Assets 33.24 Million 30.55 Million 30.23 Million 31.05 Million 16.32 Million 15.04 Million
Net PPE 23.24 Million 20.19 Million 19.71 Million 20.41 Million 11.48 Million 10.09 Million
Good Will And Intangible Assets 7.74 Million 8.38 Million 8.09 Million 8.2 Million 4.84 Million 4.94 Million
Good Will 3.34 Million 3.34 Million 3.34 Million 3.46 Million 3.43 Million 3.4 Million
Intangible Assets 4.4 Million 5.03 Million 4.75 Million 4.73 Million 1.4 Million 1.54 Million
Long-Term Investments - - - - - -
Tax Assets - - - - - -
Other Non Current Assets 2.25 Million 1.98 Million 2.41 Million 2.43 Million -16.32 Million -15.04 Million
Other Assets - 1.00 - 1.00 5.55 Million 5.04 Million
Total Liabilities 64.7 Million 35.18 Million 39.55 Million 42.44 Million 30.93 Million 27.98 Million
Total Current Liabilities 18.56 Million 18.05 Million 18.23 Million 18.22 Million 16.85 Million 14.63 Million
Account Payables 4.09 Million 4.28 Million 2.89 Million 2.21 Million 4.14 Million 3.19 Million
Tax Payables 4.44 Million 4.26 Million 3.75 Million 4.44 Million 1.87 Million 2.21 Million
Short Term Debt 1.8 Million 2.26 Million 1.75 Million 2.26 Million 694 Thousand 644 Thousand
Deferred Revenue - - - - -694 Thousand -644 Thousand
Other Current Liabilities 12.67 Million 11.5 Million 13.57 Million 13.74 Million 12.71 Million 11.43 Million
Total Non Current Liabilities 46.13 Million 17.13 Million 21.32 Million 24.21 Million 1.74 Million 2.41 Million
Long-Term Debt 26.43 Million 1.49 Million 2.45 Million 2.92 Million 1.74 Million 2.41 Million
Deferred Revenue Non Current 7.74 Million 6.76 Million 6.96 Million 6.98 Million 1.42 Million 2.1 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 11.49 Million 8.46 Million 11.49 Million 13.83 Million -1.74 Million -2.41 Million
Other Liabilities - - - - 12.33 Million 10.93 Million
Total Equity 2.06 Million 37.76 Million 48.53 Million 43.78 Million 37.55 Million 23.03 Million
Stock Holders Equity 2.06 Million 37.76 Million 48.53 Million 43.78 Million 37.55 Million 23.03 Million
Common Stock 689 Thousand 654 Thousand 651 Thousand 647 Thousand 636 Thousand 596 Thousand
Retained Earnings -121.74 Million -78.41 Million -67.27 Million -72.83 Million -119.17 Million -121.75 Million
Accumulated other comprehensive income 4.08 Million 2.94 Million 2.57 Million 3.39 Million 3.38 Million 1.63 Million
Common Stock Equity 2.06 Million 37.76 Million 48.53 Million 43.78 Million 37.55 Million 23.03 Million
Capital Lease Obligation 7.74 Million 6.76 Million 6.96 Million 6.98 Million - -
Total Investments - - - - - 5.04 Million
Total Debt 35.98 Million 10.52 Million 11.17 Million 12.17 Million 2.43 Million 3.05 Million
Net Debt 21.14 Million -9.98 Million -29.1 Million -24.78 Million -25 Million -12.47 Million

Balance Sheet Charts